OX40 as a novel target for the reversal of immune escape in colorectal cancer.

Yan, Lin-Hai; Liu, Xiao-Liang; Mo, Si-Si; Zhang, Di; Mo, Xian-Wei; Tang, Wei-Zhong.

Afiliação

Yan LH; Department of Gastrointestinal Surgery, Guangxi Medical University Cancer Hospital Nanning 530021, Guangxi Zhuang Autonomous Region, China.
Liu XL; Guangxi Clinical Research Center for Colorectal Cancer Nanning 530021, Guangxi Zhuang Autonomous Region, China.
Mo SS; Department of Surgery, Guangxi Medical University Cancer Hospital Nanning 530021, Guangxi Zhuang Autonomous Region, China.
Zhang D; Department of Gastrointestinal Surgery, Guangxi Medical University Cancer Hospital Nanning 530021, Guangxi Zhuang Autonomous Region, China.
Mo XW; Guangxi Clinical Research Center for Colorectal Cancer Nanning 530021, Guangxi Zhuang Autonomous Region, China.
Tang WZ; Department of Gastrointestinal Surgery, Guangxi Medical University Cancer Hospital Nanning 530021, Guangxi Zhuang Autonomous Region, China.

Am J Transl Res ; 13(3): 923-934, 2021.

Article em En | MEDLINE | ID: mdl-33841630